242 related articles for article (PubMed ID: 30289978)
1. LKB1 regulates PRMT5 activity in breast cancer.
Lattouf H; Kassem L; Jacquemetton J; Choucair A; Poulard C; Trédan O; Corbo L; Diab-Assaf M; Hussein N; Treilleux I; Le Romancer M
Int J Cancer; 2019 Feb; 144(3):595-606. PubMed ID: 30289978
[TBL] [Abstract][Full Text] [Related]
2. RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.
Guderian G; Peter C; Wiesner J; Sickmann A; Schulze-Osthoff K; Fischer U; Grimmler M
J Biol Chem; 2011 Jan; 286(3):1976-86. PubMed ID: 21081503
[TBL] [Abstract][Full Text] [Related]
3. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
Chen H; Lorton B; Gupta V; Shechter D
Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
[TBL] [Abstract][Full Text] [Related]
4. Biochemical Investigation of the Interaction of pICln, RioK1 and COPR5 with the PRMT5-MEP50 Complex.
Krzyzanowski A; Gasper R; Adihou H; Hart P'; Waldmann H
Chembiochem; 2021 Jun; 22(11):1908-1914. PubMed ID: 33624332
[TBL] [Abstract][Full Text] [Related]
5. The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.
Stopa N; Krebs JE; Shechter D
Cell Mol Life Sci; 2015 Jun; 72(11):2041-59. PubMed ID: 25662273
[TBL] [Abstract][Full Text] [Related]
6. NF90/NFAR (nuclear factors associated with dsRNA) - a new methylation substrate of the PRMT5-WD45-RioK1 complex.
Cox J; Esser LM; Jüdt M; Schmitz K; Reiffert K; Grimmler M; Stork B; Wesselborg S; Peter C
Biol Chem; 2022 Sep; 403(10):907-915. PubMed ID: 36040368
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for substrate recruitment to the PRMT5 methylosome.
Mulvaney KM; Blomquist C; Acharya N; Li R; Ranaghan MJ; O'Keefe M; Rodriguez DJ; Young MJ; Kesar D; Pal D; Stokes M; Nelson AJ; Jain SS; Yang A; Mullin-Bernstein Z; Columbus J; Bozal FK; Skepner A; Raymond D; LaRussa S; McKinney DC; Freyzon Y; Baidi Y; Porter D; Aguirre AJ; Ianari A; McMillan B; Sellers WR
Mol Cell; 2021 Sep; 81(17):3481-3495.e7. PubMed ID: 34358446
[TBL] [Abstract][Full Text] [Related]
8. MEP50/PRMT5 Reduces Gene Expression by Histone Arginine Methylation and this Is Reversed by PKCδ/p38δ Signaling.
Saha K; Adhikary G; Eckert RL
J Invest Dermatol; 2016 Jan; 136(1):214-224. PubMed ID: 26763441
[TBL] [Abstract][Full Text] [Related]
9. Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer.
Wang X; Qiu T; Wu Y; Yang C; Li Y; Du G; He Y; Liu W; Liu R; Chen CH; Shi Y; Pan J; Zhou J; Jiang D; Chen C
Cell Death Differ; 2021 Oct; 28(10):2931-2945. PubMed ID: 33972717
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2
Ichikawa T; Suekane A; Nakahata S; Iha H; Shimoda K; Murakami T; Morishita K
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474089
[TBL] [Abstract][Full Text] [Related]
11. Protein arginine methyltransferase 5 catalyzes substrate dimethylation in a distributive fashion.
Wang M; Fuhrmann J; Thompson PR
Biochemistry; 2014 Dec; 53(50):7884-92. PubMed ID: 25485739
[TBL] [Abstract][Full Text] [Related]
12. Myosin phosphatase and RhoA-activated kinase modulate arginine methylation by the regulation of protein arginine methyltransferase 5 in hepatocellular carcinoma cells.
Sipos A; Iván J; Bécsi B; Darula Z; Tamás I; Horváth D; Medzihradszky KF; Erdődi F; Lontay B
Sci Rep; 2017 Jan; 7():40590. PubMed ID: 28074910
[TBL] [Abstract][Full Text] [Related]
13. Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificity.
Ho MC; Wilczek C; Bonanno JB; Xing L; Seznec J; Matsui T; Carter LG; Onikubo T; Kumar PR; Chan MK; Brenowitz M; Cheng RH; Reimer U; Almo SC; Shechter D
PLoS One; 2013; 8(2):e57008. PubMed ID: 23451136
[TBL] [Abstract][Full Text] [Related]
14. PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core.
Lubyova B; Hodek J; Zabransky A; Prouzova H; Hubalek M; Hirsch I; Weber J
PLoS One; 2017; 12(10):e0186982. PubMed ID: 29065155
[TBL] [Abstract][Full Text] [Related]
15. Curcumin ameliorates PRMT5-MEP50 arginine methyltransferase expression by decreasing the Sp1 and NF-YA transcription factors in the A549 and MCF-7 cells.
Chatterjee B; Ghosh K; Suresh L; Kanade SR
Mol Cell Biochem; 2019 May; 455(1-2):73-90. PubMed ID: 30392062
[TBL] [Abstract][Full Text] [Related]
16. The Structure and Function of the PRMT5:MEP50 Complex.
Antonysamy S
Subcell Biochem; 2017; 83():185-194. PubMed ID: 28271477
[TBL] [Abstract][Full Text] [Related]
17. MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis.
Marjon K; Cameron MJ; Quang P; Clasquin MF; Mandley E; Kunii K; McVay M; Choe S; Kernytsky A; Gross S; Konteatis Z; Murtie J; Blake ML; Travins J; Dorsch M; Biller SA; Marks KM
Cell Rep; 2016 Apr; 15(3):574-587. PubMed ID: 27068473
[TBL] [Abstract][Full Text] [Related]
18. The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer.
Rengasamy M; Zhang F; Vashisht A; Song WM; Aguilo F; Sun Y; Li S; Zhang W; Zhang B; Wohlschlegel JA; Walsh MJ
Nucleic Acids Res; 2017 Nov; 45(19):11106-11120. PubMed ID: 28977470
[TBL] [Abstract][Full Text] [Related]
19. Novel PRMT5-mediated arginine methylations of HSP90A are essential for maintenance of HSP90A function in NDRG2
Ichikawa T; Shanab O; Nakahata S; Shimosaki S; Manachai N; Ono M; Iha H; Shimoda K; Morishita K
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118615. PubMed ID: 31765670
[TBL] [Abstract][Full Text] [Related]
20. Lead induces the up-regulation of the protein arginine methyltransferase 5 possibly by its promoter demethylation.
Ghosh K; Chatterjee B; Kanade SR
Biochem J; 2018 Aug; 475(16):2653-2666. PubMed ID: 30054435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
